Objectives: Because of the emergence of plasmid-mediated (mcr-1 and mcr-2 genes) and chromosomally-encoded colistin resistance, reliable methods for detecting colistin resistance/susceptibility in routine laboratories are required. We evaluated the respective performances of the BD Phoenix automated system, the newly-developed Rapid Polymyxin NP test and the broth microdilution (BMD) reference method to detect colistin resistance in Enterobacteriaceae, and particularly those producing MCR-1 and MCR-2.
INTRODUCTION
The increasing use of colistin in human medicine, and the recent discovery of plasmidmediated polymyxin resistance [1] [2] [3] [4] , highlight the need for reliable methods for polymyxin susceptibility testing.
The Clinical Laboratory Standard Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) recently gathered in a joint subcommittee, chose the broth microdilution (BMD) method as the reference method (www.eucast.org). It must be performed with sulfate salts of polymyxins (colistimethate used in human medicine shall not be used), with cation-adjusted Mueller-Hinton broth, without additive (in particular without polysorbate 80) and without treated polystyrene trays. Other methods such as, agar dilution, disk diffusion and gradient diffusion (E-test) have been ruled out. However, this gold standard BMD method is difficult to performed in routine laboratories since it requires qualified staff, is time-consuming, and requires manual preparation of antibiotic solutions [5] .
Automated dilution methods such as those performed by the BD Phoenix system could be an alternative for the screening of colistin resistance for laboratories that cannot perform manual BMD. However, the performance of this automate for colistin susceptibility testing, especially its accuracy for the detection of isolates exhibiting a plasmid-mediated colistin resistance, have never been evaluated. Recently, a rapid colorimetric test, the Rapid Polymyxin NP test, has been developed for detecting polymyxin resistance in Enterobacteriaceae within 2 hours [6] .
The objective of this study was to evaluate the performance of the BD Phoenix automated system to detect plasmid-mediated and chromosomally-encoded colistin resistance, using a collection of clinical enterobacterial isolates. We also aimed to compare their performances to those of the Rapid Polymyxin NP test and the BMD reference method. 
MATERIAL AND METHODS

Bacterial
Susceptibility testing
Reference antimicrobial susceptibility testing
The BMD method was performed according to the EUCAST/CLSI joined guidelines according to the EUCAST breakpoints [7] , i.e. isolates with MICs of colistin 2 mg/l were categorized as susceptible although those with MICs > 2 mg/l were resistant.
BD Phoenix automated system
Colistin susceptibility testing was assessed using the Phoenix automated system (BD Phoenix 100, BD Diagnostic systems, Le Pont de Claix, France), which performs automated BMD method. The panel selected to perform this evaluation was the Gram-negative panel NMIC-93, using the BMD method for colistin concentrations ranging from 0.5 to 4 mg/l in order to cover the EUCAST breakpoints [7] . The bacterial suspension and the panel inoculation were performed according to the manufacturer's guidelines. Panels were incubated up to 16 h at 35±2°C under ambient air, and results were interpreted with the BD EpiCenter software.
Rapid Polymyxin NP test
The Rapid Polymyxin NP test is based on the detection of the glucose metabolism related to bacterial growth in presence of a fixed concentration of colistin (3.75 mg/l) in cation-adjusted MH broth medium [6] . Formation of acid metabolites consecutive to the glucose metabolism is evidenced by a color change (orange to yellow) of the pH indicator (red phenol). The test is positive (colistin resistance) if a strain grows in presence of colistin, whereas it is negative (colistin susceptibility) if a strain does not grow in presence of colistin. Results of the Rapid Polymyxin NP test were read at 2 h of incubation at 35±2°C in ambient air.
Molecular characterization of the colistin resistance. Molecular mechanisms responsible for plasmid-mediated (mcr-1 and mcr-2 genes) and chromosomally-encoded (pmrA, pmrB, phoP, phoQ, mgrB, and crrB alterations) colistin resistance were determined as described previously [1, 2, [8] [9] [10] [11] [12] .
Results analysis. The results obtained with the BD Phoenix system and the Rapid
Polymyxin NP test were compared to those obtained with the reference BMD method.
Discrepancies were determined for each method in order to assess their performance to detect colistin resistance. For strains for which discrepant susceptibility results were obtained, the isolates were retested with the three methods. Unsolved discrepancies were then maintained in the database for performance evaluation. Errors were ranked as follows: a very major error (VME) was defined when isolates were categorized as susceptible using the Phoenix system or the Rapid Polymyxin NP test but resistant by the BMD method (false-susceptible result), while a major error (ME) was defined when isolates were found resistant using the Phoenix system or the Rapid Polymyxin NP test, but were found susceptible by using the BMD method (false-resistant result). The number of resistant isolates, and the number of susceptible isolates were used as denominators for VME and ME calculations, respectively. Acceptance criteria that provide requirements, and specifications to evaluate performances of antimicrobial susceptibility test devices were those defined by the ISO standards (VME and ME must be 3%) [13] .
RESULTS
The features of the 123 enterobacterial isolates included in this study to evaluate the performance of the BD Phoenix system and the Polymyxin NP test for determining colistin susceptibility are presented in the Table. Fourty isolates defined as colistin-susceptible according to the results of the BMD method (MICs of colistin ranging from 0.12 to 2 μg/ml) were found susceptible by the BD Phoenix system (Table) . While a single susceptible K. pneumoniae isolate with an MIC of colistin at 2 mg/l was found resistant using the Rapid Polymyxin NP test. The MIC value of colistin for this same isolate as determined by the BD Phoenix system was underestimated (MIC 0.5 mg/l) but the isolate was well categorized as susceptible.
Out of the 83 colistin-resistant enterobacterial isolates (MICs of colistin ranging from 4 to higher than 128 mg/l), the Phoenix system failed to detect colistin resistance for seven 
DISCUSSION
Out of the 40 colistin-susceptible enterobacterial isolates, no ME (i.e. false resistance)
was found with the Phoenix system, and only a single susceptible K. pneumoniae isolate with an MIC of colistin at 2 mg/l (therefore just below the EUCAST breakpoint value > 2 mg/l) was falsely identified as colistin resistant with the Rapid Polymyxin NP test revealing a ME rate of 2.5%.test
Out of the 83 colistin-resistant enterobacterial isolates, the BD Phoenix system and the Rapid Polymyxin NP test showed excellent performances to detect the 13 isolates with plasmid-mediated colistin resistance regardless of the level of resistance. However, ten VME (i.e. false susceptibility) were found with the Phoenix system whereas a single VME was found with the Rapid Polymyxin NP test (Table) . A high VME rate of 12% was thus found with the BD Phoenix system, whereas a low VME rate of 1.2% was found with the Rapid Polymyxin NP test. The single colistin-resistant E. coli isolate that was not detected with the BD Phoenix system and the Rapid Polymyxin NP test, presented a low level of resistance (MIC of colistin at 8 mg/l). Its mechanism of colistin resistance remains unknown (neither chromosomally-encoded mutations in genes known to be involved in lipopolysaccharide modifications, i.e. mgrB, pmrAB and phoPQ genes, nor plasmid-mediated mcr-1 and mcr-2 genes were detected).
The S. enterica isolate identified as susceptible (MIC = 2 mg/l) with the BD Phoenix system presented a low level of colistin resistance (MIC = 4 mg/l) and its mechanism of resistance remains unknown (neither chromosomal mutations, nor plasmid-mediated resistance).
The K. pneumoniae resistant isolate and the seven Enterobacter spp. resistant isolates not detected with the BD Phoenix system exhibited MIC values of colistin ranging from 16 to higher than 128 mg/l and were identified as colistin resistant with the Rapid Polymyxin NP test. During the determination of MICs by the BMD method, skipped wells (i.e. wells that exhibit no growth although growth does occur at higher concentrations) were observed for 88% of those isolates (the K. pneumoniae isolate and six Enterobacter spp. isolates). This observation suggests that the failure of the BD Phoenix system to detect colistin resistance in those isolates could be related to a heteroresistance phenotype (defined by the presence of two subpopulations exhibiting different susceptibilities to colistin) [14] . The skipped wells observed during the MIC determination of those isolates by the BMD method are mainly for dilutions comprised between 0.125 and 4 mg/l. The Phoenix panel used in this study contained dilutions of colistin ranging from 0.5 to 4 mg/l. It is therefore likely that the failure of detection of heteroresistance for those isolates was linked to the absence of testing at higher colistin concentrations. The low sensitivity to detect colistin heteroresistance has already been described for another automated system, i.e. the bioMérieux Vitek system [15] .
The limitation of our study could be the absence of testing of non-fermenting Gram negative rods in our collection. 
